

08 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/complement-therapeutics-announces-fda-fast-track-designation-for-ctx001-for-the-treatment-of-geographic-atrophy-secondary-to-amd-302655523.html

08 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/complement-therapeutics-receives-fda-ind-clearance-to-advance-ctx001-into-opti-gain-a-phase-iii-clinical-trial-in-geographic-atrophy-secondary-to-amd-302577045.html